
New Protein Discovery Opens Path to Sickle Cell Treatment
Scientists at Harvard discovered that blocking a protein called BACH2 could help treat sickle cell disease by boosting protective fetal hemoglobin levels. This breakthrough opens an entirely new treatment pathway that works differently from existing therapies.







